![](https://newsroom.psyma.com/de/wp-content/uploads/2019/07/Injection-device-psyma-723x480.jpeg)
26.07.2019
Is the patient’s voice always being heard by pharma and biotech companies when developing self-injection devices?
The priorities between chronic and acute care can vary greatly from having genuine benefits to helping patients and caregivers cope better with their treatment to ... mehr